The trading halt is a procedural step ahead of pricing, but the dilutive overhang from the Global Offering is a near-term negative for the stock. Monitor for the pricing announcement later today — a larger-than-expected offering or a discount to market could amplify the bearish reaction.
Price Chart
Executive Summary
Nanobiotix has temporarily halted trading on Euronext Paris to finalize allocations and announce pricing for its previously announced Global Offering, which includes a U.S. ADS offering and an international offering of ordinary shares and pre-funded warrants. The halt is procedural and expected to last until later today, but the capital raise will dilute existing shareholders.
Key Facts
- Trading of ordinary shares on Euronext Paris halted from 9:00 a.m. CEST on May 21, 2026, at the Company's request.
- Halt is to confirm allocations and announce pricing of the Global Offering (U.S. ADS offering + international offering of ordinary shares and pre-funded warrants).
- Trading expected to resume at approximately 3:30 p.m. CEST / 9:30 a.m. New York time on May 21, 2026.
- The offering size and pricing terms are not disclosed in this press release.
Financial Impact
Undisclosed amount; the offering will dilute existing shareholders, but the exact dilution percentage is unknown until pricing is announced.
Risk Factors
- Dilution from the Global Offering will reduce EPS and ownership percentage for existing shareholders.
- Pricing at a discount to the current market price could trigger a sell-off.
- If the offering is larger than anticipated, it may signal urgent capital needs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3299023 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $30.26 | awaiting T+20 | — | $31.53 (+4.20%) |
Oct 20, 2026 6d ago | 6-K | $25.83 | awaiting T+20 | — | $31.53 (+22.07%) |
Oct 1, 2026 25d ago | 6-K | $25.75 | awaiting T+20 | — | $31.53 (+22.45%) |
Oct 1, 2026 25d ago | Press Release | $25.75 | awaiting T+20 | — | $31.53 (+22.45%) |
Sep 24, 2026 4w ago | 6-K | $33.31 $29.36 | ▲ +11.86% | ▲ +10.38% | $31.53 (+5.34%) |
Sep 24, 2026 4w ago | 6-K | $33.31 $29.36 | ▼ −11.86% | ▼ −10.38% | $31.53 (−5.34%) |
Sep 24, 2026 4w ago | Press Release | $33.31 $29.36 | ▼ −11.86% | ▼ −10.38% | $31.53 (−5.34%) |
Sep 22, 2026 4w ago | Press Release | $35.24 $25.83 | ▼ −26.70% | ▼ −27.39% | $31.53 (−10.53%) |
Sep 14, 2026 6w ago | 6-K | $35.73 $23.40 | ▼ −34.51% | ▼ −36.77% | $31.53 (−11.75%) |
Jul 31, 2026 12w ago | 6-K | $38.89 $40.64 | ▲ +4.50% | ▲ +3.26% | $31.53 (−18.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers